全文获取类型
收费全文 | 9435篇 |
免费 | 481篇 |
国内免费 | 47篇 |
专业分类
耳鼻咽喉 | 94篇 |
儿科学 | 212篇 |
妇产科学 | 126篇 |
基础医学 | 1281篇 |
口腔科学 | 176篇 |
临床医学 | 499篇 |
内科学 | 2187篇 |
皮肤病学 | 115篇 |
神经病学 | 826篇 |
特种医学 | 246篇 |
外科学 | 1715篇 |
综合类 | 31篇 |
预防医学 | 259篇 |
眼科学 | 296篇 |
药学 | 689篇 |
中国医学 | 22篇 |
肿瘤学 | 1189篇 |
出版年
2023年 | 57篇 |
2022年 | 103篇 |
2021年 | 152篇 |
2020年 | 87篇 |
2019年 | 152篇 |
2018年 | 166篇 |
2017年 | 140篇 |
2016年 | 162篇 |
2015年 | 165篇 |
2014年 | 195篇 |
2013年 | 262篇 |
2012年 | 404篇 |
2011年 | 448篇 |
2010年 | 291篇 |
2009年 | 233篇 |
2008年 | 477篇 |
2007年 | 484篇 |
2006年 | 506篇 |
2005年 | 567篇 |
2004年 | 575篇 |
2003年 | 540篇 |
2002年 | 537篇 |
2001年 | 268篇 |
2000年 | 257篇 |
1999年 | 231篇 |
1998年 | 158篇 |
1997年 | 111篇 |
1996年 | 108篇 |
1995年 | 81篇 |
1994年 | 82篇 |
1993年 | 82篇 |
1992年 | 184篇 |
1991年 | 173篇 |
1990年 | 173篇 |
1989年 | 159篇 |
1988年 | 143篇 |
1987年 | 121篇 |
1986年 | 106篇 |
1985年 | 88篇 |
1984年 | 90篇 |
1983年 | 86篇 |
1982年 | 48篇 |
1981年 | 37篇 |
1980年 | 36篇 |
1979年 | 54篇 |
1978年 | 35篇 |
1977年 | 45篇 |
1976年 | 35篇 |
1972年 | 35篇 |
1971年 | 25篇 |
排序方式: 共有9963条查询结果,搜索用时 15 毫秒
991.
992.
993.
Kenji Yamaguchi Emi Kanno Hiromasa Tanno Ayako Sasaki Yuki Kitai Takayuki Miura Naoyuki Takagi Miki Shoji Jun Kasamatsu Ko Sato Yuka Sato Momoko Niiyama Yuka Goto Keiko Ishii Yoshimichi Imai Shinobu Saijo Yoichiro Iwakura Masahiro Tachi Kazuyoshi Kawakami 《The Journal of investigative dermatology》2021,141(1):164-176.e8
994.
Previous studies have suggested that psychological stress delays cutaneous barrier recovery following acute barrier disruption, and that sedative drugs block this delay. A sedative effect of some odorants has been reported. In the present study, we demonstrate that odorant inhalation affects cutaneous barrier homeostasis in both mice and humans. Odorants with a sedative effect prevented the delay of skin barrier recovery induced by stress after acute barrier disruption. Other odorants did not show this effect. 相似文献
995.
Kishi Shoji Matsumoto Hidetaka 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2022,260(11):3405-3417
Graefe's Archive for Clinical and Experimental Ophthalmology - Pachychoroid spectrum diseases are regarded as being different manifestations of a common pathogenic process. We suggest that... 相似文献
996.
Miyanaga A Gemma A Noro R Kataoka K Matsuda K Nara M Okano T Seike M Yoshimura A Kawakami A Uesaka H Nakae H Kudoh S 《Molecular cancer therapeutics》2008,7(7):1923-1930
To ascertain the potential for histone deacetylase (HDAC) inhibitor-based treatment in non-small cell lung cancer (NSCLC), we analyzed the antitumor effects of trichostatin A (TSA) and suberoylanilide hydroxamic acid (vorinostat) in a panel of 16 NSCLC cell lines via 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. TSA and vorinostat both displayed strong antitumor activities in 50% of NSCLC cell lines, suggesting the need for the use of predictive markers to select patients receiving this treatment. There was a strong correlation between the responsiveness to TSA and vorinostat (P < 0.0001). To identify a molecular model of sensitivity to HDAC inhibitor treatment in NSCLC, we conducted a gene expression profiling study using cDNA arrays on the same set of cell lines and related the cytotoxic activity of TSA to corresponding gene expression pattern using a modified National Cancer Institute program. In addition, pathway analysis was done with Pathway Architect software. We used nine genes, which were identified by gene-drug sensitivity correlation and pathway analysis, to build a support vector machine algorithm model by which sensitive cell lines were distinguished from resistant cell lines. The prediction performance of the support vector machine model was validated by an additional nine cell lines, resulting in a prediction value of 100% with respect to determining response to TSA and vorinostat. Our results suggested that (a) HDAC inhibitors may be promising anticancer drugs to NSCLC and (b) the nine-gene classifier is useful in predicting drug sensitivity to HDAC inhibitors and may contribute to achieving individualized therapy for NSCLC patients. 相似文献
997.
Chihiro Hiramatsu Amanda D. Melin Filippo Aureli Colleen M. Schaffner Misha Vorobyev Yoshifumi Matsumoto Shoji Kawamura 《PLoS Clinical Trials》2008,3(10)
Trichromatic primates have a ‘red-green’ chromatic channel in addition to luminance and ‘blue-yellow’ channels. It has been argued that the red-green channel evolved in primates as an adaptation for detecting reddish or yellowish objects, such as ripe fruits, against a background of foliage. However, foraging advantages to trichromatic primates remain unverified by behavioral observation of primates in their natural habitats. New World monkeys (platyrrhines) are an excellent model for this evaluation because of the highly polymorphic nature of their color vision due to allelic variation of the L-M opsin gene on the X chromosome. In this study we carried out field observations of a group of wild, frugivorous black-handed spider monkeys (Ateles geoffroyi frontatus, Gray 1842, Platyrrhini), consisting of both dichromats (n=12) and trichromats (n=9) in Santa Rosa National Park, Costa Rica. We determined the color vision types of individuals in this group by genotyping their L-M opsin and measured foraging efficiency of each individual for fruits located at a grasping distance. Contrary to the predicted advantage for trichromats, there was no significant difference between dichromats and trichromats in foraging efficiency and we found that the luminance contrast was the main determinant of the variation of foraging efficiency among red-green, blue-yellow and luminance contrasts. Our results suggest that luminance contrast can serve as an important cue in short-range foraging attempts despite other sensory cues that could be available. Additionally, the advantage of red-green color vision in primates may not be as salient as previously thought and needs to be evaluated in further field observations. 相似文献
998.
999.
1000.
Chen F Sato K Fujinaga T Sonobe M Shoji T Sakai H Miyahara R Bando T Okubo K Hirata T Date H 《World journal of surgery》2008,32(10):2213-2217
BACKGROUND: Pulmonary metastasectomy has become the standard therapy for various metastatic malignancies to the lungs; however, few data have been available about lung metastasectomy for hepatocellular carcinoma. To confirm the role for resection of pulmonary metastases for such tumors, we reviewed our institutional experience. METHODS: Between 1993 and 2005, 12 patients with pulmonary metastases from hepatocellular carcinomas underwent complete pulmonary resection. All patients had undergone curative resection of their primary hepatocellular carcinomas and also had obtained or had obtainable locoregional control of their primaries. Various perioperative variables were investigated retrospectively to analyze the possible prognostic factors for overall survival and pulmonary metastases-free survival after pulmonary metastasectomy. RESULTS: Nine patients were male and three were female (median age, 53 (range, 43-80) years). Overall survival rate after metastasectomy was 80.8%, 57.7%, and 28.9% at 1, 2, and 5 years, respectively. Pulmonary metastases-free survival rate was 64.2%, 32.1%, and 21.4% at 1, 2, and 5 years, respectively. Five patients presented recurrences in the remaining liver before pulmonary metastases, but hepatic recurrences at this interval did not affect an overall survival after pulmonary metastasectomies. Two patients had undergone living-related liver transplantation. The maximum tumor size of the pulmonary metastasis < 3 cm was the only favorable prognostic factor for overall survival (P = 0.0006), whereas there was no significant prognostic factor for pulmonary metastases-free survival. CONCLUSIONS: Pulmonary metastasectomy for hepatocellular carcinoma in selected patients was well justified when the maximum tumor size was <3 cm. 相似文献